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Abstract 11 
Phosphorylation is a reversible post-translational modification, playing a vital role in protein function. In T cells, 12 
protein phosphorylation is the key mechanism regulating T cell receptor – driven signaling pathways. In order to gain 13 
insights into the phosphoproteome evolution of T cell activation, we performed a large-scale quantitative 14 
phosphoproteomics study of Jurkat E6.1 (wild type) and Jurkat gamma1 (Phospholipase gamma1 null) cell clones 15 
upon costimulation with anti-CD3 and anti-CD28 antibodies at times ranging from 15 min to as long as 120 min. In 16 
total, we identified 5585 phosphopeptides belonging to 2008 phosphoproteins from both cell clones. We detected 130 17 
and 114 novel phosphopeptides in Jurkat E6.1 and Jurkat gamma1 clones, respectively. A significantly lower number 18 
of proteins containing regulated phosphorylation sites were identified in Jurkat gamma1 in comparison to Jurkat E6.1, 19 
reflecting the vital role of Phospholipase gamma1 in T cell signaling. Several new phosphorylation sites from 20 
lymphocyte-specific protein tyrosine kinase (Lck) were identified. Of these, serine-121 showed significant changes in 21 
JE6.1 while only small changes in the Jgamma1 clone. Our data may contribute to the current human T cell 22 
phosphoproteome and provide a better understanding on T cell receptor signaling. Data are available via 23 
ProteomeXchange with identifier PXD002871. 24 
 25 
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  29 
1. Introduction 30 
Phosphorylation is one of the most frequent PTMs and plays a vital role in the function of proteins. Phosphorylation 31 
and dephosphorylation events turn protein enzymes on/off, thereby altering various cellular processes including T cell 32 
receptor (TCR) - driven signaling pathways. In T cells, TCR stimulation leads to a series of cellular signals which are 33 
mainly regulated by phosphorylation events catalyzed by protein kinases. Engagement of the TCR-CD3 complex 34 
changes the structure of intracellular CD3 subunits and facilitates their phosphorylation by lymphocyte-specific 35 
protein tyrosine kinase (Lck) [1, 2]. This phosphorylation of the CD3 chains initiates the early TCR signals, including 36 
the phosphorylation of zeta-chain-associated protein kinase 70 (ZAP-70) and the formation of a complex between the 37 
linker for activation of T cell (LAT) and the SH2 domain-containing leukocyte protein of 76 kDa (SLP-76) [3]. These 38 
early signals then activate phospholipase C gamma 1 (PLCγ1), an important enzyme that catalyzes the hydrolysis of 39 
phosphatidylinositol bisphosphate (PIP2) to diacylglycerol (DAG) and inositol trisphosphate (IP3) [3, 4]. DAG and IP3 40 
aid the signal transduction to the nucleus by activating or enhancing several transcriptional factors such as the 41 
nuclear factor of activated T cells (NFAT), leading to cytokine secretion. The stimulation of the TCR also regulates 42 
actin and cytoskeleton remodeling and causes changes in the immunological synapse [5, 6]. 43 
The study of cell signaling concentrates on the phosphorylation/dephosphorylation of proteins or kinases participating 44 
in various signal transduction pathways. Biological studies using traditional biochemical and immunological 45 
techniques often focus only on individual parts of cell signaling pathways and are unable to study new 46 
phosphorylation sites (P-sites) if no antibodies are available [6, 7]. Over recent years, the development of 47 
phosphoproteomics quantitative approaches for large-scale and systematic analysis of cell signaling, including TCR 48 
signaling, has been improved [8-12]. Jurkat cells, including both the wild type and mutant clones, have been widely 49 
used for studying T cell signaling in humans [13]. Different T cell signaling studies using Jurkat cells aimed to reveal 50 
the phosphorylation dynamics upon TCR/CD3 stimulation [10], phorbol 12-myristate 13-acetate (PMA) and ionomycin 51 
activation [14], and combination of TCR/CD3 stimulation with other stimuli such as anti-CD28 or anti-CD4 antibodies 52 
[8, 9, 12]. Furthermore, phosphoproteomics studies on TCR signaling attempted to elucidate the effects of certain 53 
proteins of the TCR signaling network such as ZAP-70 [12], SLP-76 [8], and LAT [15] on the phosphorylation profile 54 
of T cells upon TCR stimulation (CD3 alone or CD3/CD28 costimulation) using available mutant Jurkat T cell clones. 55 
These quantitative phosphoproteomics studies produced big datasets of regulated P-sites in response to T cell 56 
activation and started out a new strategy using MS-based quantitative methods for systematic cell signaling studies. 57 
This work presents a large-scale quantitative phosphoproteomics study of human Jurkat T cells, including the Jurkat 58 
E6.1 (JE6.1 – wild type) and the Jurkat gamma1 (Jgamma1 – PLCγ1 null) clones upon costimulation with anti-59 
CD3/anti-CD28 antibodies. Our aims were to broaden current knowledge on the human Jurkat T cell 60 
phosphoproteome and to evaluate the effects of PLCγ1 on the phosphorylation dynamics of stimulated T cells for a 61 
better understanding of TCR signaling. In total, we detected 5585 phosphopeptides corresponding to 2008 62 
phosphoproteins from both cell clones. The significantly lower phosphorylation changes in Jgamma1 may imply the 63 
vital role of PLCγ1 on TCR signaling pathways. Interestingly, we detected several novel high confidence P-sites from 64 
Lck in response to TCR costimulation, of which serine-121 is among the most remarkable. 65 
 66 
2. Materials and methods 67 
 68 
2.1. Cell culture and activation 69 
JE6.1 and Jgamma1 cells were obtained from the American Type Culture Collection (Manassas, VA, USA) and 70 
cultured according to their guidelines. Previously to activation, cells were incubated in serum-free RPMI-1640 71 
medium at a density of 3×10
6
 cells/mL for 6 h. Afterwards, cells were washed and reconstituted at a density of 72 
2.5×10
7
 cells/mL in ice-cold serum-free RPMI-1640 medium. For each time point, 2.5×10
7
 cells were treated with anti-73 
CD3 (clone OKT3, eBiosciences) and anti-CD28 (clone CD28.2, eBioscience) monoclonal antibodies, at a 74 
concentration of 5 μg/mL of each antibody, for 30 min at 4 
o
C. After such time, the activation was initiated by 75 
collecting and resuspending cells in serum-free RPMI-1640 medium at 37 
o
C containing 8.5 μg/mL of goat anti-76 
mouse polyclonal IgG antibody (Invitrogen, Camarillo, CA, USA). Cell density for activation was of 2.5×10
7
 cells/mL. 77 
Activation was stopped at assigned time points (15, 30, 60, 120 and 1440 min) by diluting cell cultures with 10-fold 78 
excess of ice-cold PBS. The cell culture without antibody treatment (0 min) was used as the control. 79 
 80 
2.2. Protein extraction and digestion 81 
Cell pellets were suspended in lysis buffer (4% (w/v) SDS, 100 mM Tris/HCl, pH 7.6, 0.1 M DTT) and incubated at 95 82 
o
C for 5 min. To allow for complete cell disruption, the cell extract was sonicated 5 times for 5 s (Sonic Vibracell TM). 83 
The cell debris was removed by centrifugation at 16000×g for 20 min at 13 
o
C. Protein concentration measurement 84 
was performed with the Bradford Protein Assay (Bio-Rad, CA, USA). Five biological replicates from each clone were 85 
processed.  86 
Protein was digested with Sequencing Grade Modified Trypsin (Promega, Madison, WI, USA) using the FASP (Filter 87 
Aided Sample Preparation) digestion protocol [16]. Briefly, 80 µg of protein corresponding to each time point were 88 
loaded to a 10-kDa Amicon Ultra-0.5 centrifugal filter (Millipore, Watford, UK). The protein mixture was washed three 89 
times by adding 200 µl of UA buffer (8 M Urea, 0.1 M Tris/HCl pH 8.5) to the filter and centrifuging at 14000×g for 10 90 
min at 13 
o
C. Next, proteins were alkylated with 100 µl of alkylation buffer (0.05M IAA, 8M Urea, 0.1 M Tris/HCl pH 91 
8.5) in the dark for 20 min at 25 
o
C. Subsequently, the protein extract was washed three times with 100 µl of UA 92 
buffer and three times with 100 µl of 200 mM triethylammonium bicarbonate (TEAB). Trypsin digestion was 93 
performed at 37 °C for 18 h using an enzyme-to-protein ratio of 5:100. Tryptic peptides were eluted by the addition of 94 
3×100 µl of 200 mM TEAB followed by a centrifugation at 14000×g for 15 min at 13 
o
C. 95 
 96 
2.3. Peptide labeling by isobaric tandem mass tag 97 
Each tryptic peptide mixture obtained from 80 µg of protein extract was labeled with tandem mass tags (TMT) 98 
(Thermo Scientific, Rockford, IL, USA) based on the standard procedure. In short, the tryptic peptide mixtures were 99 
evaporated to final volumes of about 60 µl. Each TMT reagent was dissolved in 41 µl of LC/MS-grade ACN (Sigma-100 
Aldrich) and added to the corresponding peptide mixture for labeling. After one hour, the labeling reaction was 101 
stopped by adding 8 µl of 5% hydroxylamine. Six labeled peptide mixtures were combined in a low-bind 1.5 mL 102 
Eppendorf tube, evaporated, and desalted using a C18 SPE cartridge (3 mL, 15 mg, Agilent Technologies, USA) 103 
before separation by Strong Cation Exchange (SCX) chromatography. 104 
 105 
2.4. Separation of peptides by Strong cation exchange chromatography 106 
Peptide separation by SCX chromatography was performed on an Agilent 1100 HPLC system (Agilent Technologies, 107 
Waldbronn, Germany) using a Polysulfoethyl A TM, 50×2.1 mm, 5 µm, 200 Å column. Peptides were suspended in 108 
200 µl of SCX buffer A (30% ACN, 0.1% formic acid) and loaded onto the column at 200 µl/min of 100% SCX buffer 109 
A. Bound peptides were eluted by linear gradient of SCX buffer B (30% ACN, 0.1% formic acid, 500 mM NH4Cl) from 110 
0 to 25% in 38 min and then to 100% in 20 min. For each injection, samples were separated and collected in 6 final 111 
fractions (Figure S1). Each fraction was cleaned up by solid phase extraction before the subsequent phosphopeptide 112 
enrichment experiments. 113 
 114 
2.5. Phosphopeptide enrichment  115 
Enrichment of phosphopeptides by sequential Immobilized Metal Ion Affinity chromatography (IMAC) and Titanium 116 
dioxide (TiO2) chromatography was carried out according to previous studies [17, 18]. Briefly, the IMAC resin (Phos-117 
Select iron affinity gel, Sigma, St.Louis, MO) was washed three times and added to each peptide extract. The 118 
mixtures were incubated for 90 min at 20 °C with end-to-end rotation in a low-bind 0.5 mL Eppendorf tube. 119 
Afterwards, samples were transferred to a Mobicol mini-column (MoBiTec, Germany) and washed three times with 120 
200 μl of 250 mM Acetic acid /30% acetonitrile. Phosphopeptides were eluted with 3×50 μl of 0.5% NH4OH into a 1.5 121 
mL Eppendorf tube containing 20 μl of 10% formic acid. The non-retained fraction was evaporated and resuspended 122 
in 50 µl of 1 M glycolic acid, 5% TFA, 80% acetonitrile for the subsequent TiO2 phosphopeptide enrichment. The TiO2 123 
mini-column was prepared by loading TiO2 slurry (Titansphere, GL Sciences, Japan) onto a GelLoader Tip as 124 
previously described [19]. This column was equilibrated with 50 µl of 1 M glycolic acid, 5% TFA, 80% acetonitrile. The 125 
sample was loaded onto the column using a syringe; then, the column was washed sequentially with 10 μl of 1 M 126 
glycolic acid, 5% TFA, 80% acetonitrile, then 20 μl of 80% acetonitrile, 1% TFA and, finally, 5 μl of water. Bound 127 
phosphopeptides were eluted with 20 μl of 0.5% NH4OH followed by 5 μl of 30% acetonitrile. Each eluate was then 128 
acidified with 2 μl of formic acid. 129 
 130 
2.6. LC-MS
n
 Analysis 131 
All IMAC and TiO2 phosphopeptide fractions were analyzed separately by LC-MS
n
 using an LTQ-Orbitrap XL 132 
instrument equipped with a nanoESI ion source (Proxeon, Odense, Denmark). Samples were evaporated to dryness 133 
and redissolved in 20 µl of 1% formic acid and 5% MeOH. The HPLC system was composed of an Agilent 1200 134 
capillary nano pump, a binary pump, a thermostated microinjector and a micro switch valve. Separation was carried 135 
out using a C18 pre-concentration cartridge (Agilent Technologies) connected to a 15 cm-long 100 μm i.d. C18 136 
column (Nikkyo Technos Co, Japan). Separation was done at 0.4 μl/min using a linear ACN gradient from 0 to 40% in 137 
180 min (solvent A: 0.1% formic acid, solvent B: acetonitrile 0.1% formic acid). The LTQ-Orbitrap instrument was set 138 
up in the positive ion mode with a spray voltage of 1.8 kV. The scan range of each full MS was m/z 400-2000. The 139 
spectrometric analysis was performed in an automatic data dependent mode. A full scan followed of 1 HCD and 1 140 
CID MS/MS for the 3 most abundant signals were acquired. A subsequent MS
3
 scan was performed when a neutral 141 
loss of -98, -49, or -32.7 m/z (loss of H3PO4 for the +1, +2, and +3 charged ions, respectively) was detected in the 142 
CID MS/MS among the 5 most intense ions. Dynamic exclusion was set to 1 with a time window of 45 s to minimize 143 
the redundant selection of precursor ions. 144 
Combination of CID and HCD information for peptide identification and quantitation, respectively, provides an efficient 145 
method for quantitative shotgun proteomics [20]. Due to the rich sequence information offered by the CID spectra, 146 
CID is preferred for peptide identification to HCD in the Orbitrap XL. CID spectra, however, do not usually contain 147 
information on the low-mass reporter ions due to the ion trap scan limitations. Contrarily, the higher fragmentation 148 
energy of HCD and the absence of lower-mass limits make this method optimal for monitoring reporter ions. 149 
 150 
2.7. Database search and quantitative analysis 151 
Database search was carried out using multiple search engines including SEQUEST (Bioworks v3.3, ThermoFisher, 152 
San Jose, CA) [21], OMSSA (version 2.1.4)[22], and EasyProt [23]. The database search workflow was as previously 153 
described [24, 25]. In brief, Thermo RAW files were processed using the EasierMgf software, which generates 154 
separate files for the MS/MS and MS
3
 data, respectively. At the same time, EasierMgf combines the low mass range 155 
data from each HCD MS/MS spectrum with the corresponding CID data obtained for the same precursor in the scan 156 
cycle into single MS/MS and MS
3
 spectra. These MGF files containing hybrid HCD-extended MS/MS and MS
3
 CID 157 
spectra, respectively, were used as input for the different search engines. Each search engine was run against the 158 
Human Swiss-Prot database (Human Swiss-Prot, release 4-11) using the target-decoy strategy [26]. Database 159 
searches for MS
2
 and MS
3
 were performed separately. MS
2
 searches were performed with the following parameters: 160 
parent tolerance, 20 ppm; fragment tolerance, 0.8 Da; enzyme, trypsin; missed cleavages, 1; fixed modifications, 161 
TMTsixplex (N-terminal, K), carbamidomethyl (C); variable modifications, oxidation (M), phosphorylation (S, T, Y). For 162 
the MS
3
 searches, the setup parameters included: parent tolerance, 2 Da; fragment tolerance, 0.8 Da; enzyme, 163 
trypsin; fixed modifications, TMTsixplex (N-terminal, K), carbamidomethyl (C); variable modifications, oxidation (M), 164 
phosphorylation (S, T, Y), dehydration (S, T). The results from the different search engines were combined and 165 
filtered using the Integrator software. Only those hits detected from at least two search engines were considered as 166 
positive identifications [25]. When a peptide assigned to 2 or more proteins the first accession number in our data 167 
was considered in following discussions. The mass spectrometry proteomics data have been deposited to the 168 
ProteomeXchange Consortium [27] via the PRIDE partner repository with the dataset identifier PXD002871. 169 
 170 
The location of P-sites was evaluated according to the Q-Ascore algorithm by using the Integrator software [25, 28]. 171 
P-sites with Q-Ascore≥19 were considered of high confidence. To describe our collections of non-redundant 172 
identifications, except when indicated, phosphopeptides with different assignation of the phosphate position were 173 
counted separately irrespective of their Q-Ascore value.  174 
 175 
Quantitative information of the peptides detected either from the MS/MS or MS
3
 fragmentation data was extracted 176 
from the HCD MS
2
 data already embedded in these hybrid HCD/CID spectra by EasierMgf. When a peptide was 177 
identified by both MS
2
 and MS
3
 spectra, only MS
2
 spectra was considered for quantitation. DanteR [29] was used for 178 
relative quantification and statistical analysis of TMT-labeled peptides. All scans with signals for at least one reporter 179 
ion were considered for quantification. Before DanteR analysis, intensity data was normalized using the median of 180 
non-phosphorylated peptides for each reporter ion. DanteR ANOVA was performed at peptide level, with a 181 
requirement of at least two measurements, by comparing treated versus control peptides using a linear model. 182 
Peptides were ordered using median and minimum number of peptides was set to 1 and maximum to 1000. Finally, 183 
p-values were adjusted by using the Benjamini & Hochberg False Discovery Rate (FDR) correction. Regulated 184 
peptides were determined using an adjusted p-value cutoff of 0.05 and a fold change lower than 0.67 (down) or 185 
higher than 1.5 (up). 186 
 187 
2.8. Biological analysis 188 
Phosphorylation Motif Analysis – The motifs of the regulated P-sites were obtained using the Motif-X algorithm using 189 
the following parameters: foreground format, MS/MS; Extend, IPI Human proteome; central characters, S or T; width, 190 
13; background, IPI Human proteome. Occurrences and Significance parameters were set depending of the 191 
collection foreground size (see Figure S2). The other parameters were set following the Motif-X algorithm’s default 192 
profile [30]. 193 
KEGG pathway analysis – KEGG pathway analysis – Proteins containing regulated P-sites were mapped to the 194 
KEGG pathways using DAVID Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.gov) [31] and the whole Homo 195 
sapiens genome as background.   196 
 197 
2.9. Western blot analysis of Lck 198 
Equal amounts (25 µg) of protein from each time point were diluted 1:4 with 5X SDS-PAGE gel loading buffer (0.25M 199 
Tris-HCl, pH 6.8; 15% SDS; 50% glycerol; 25% β-mercaptoethanol; 0.01% bromophenol blue) and incubated at 95 
o
C 200 
for 10 min. Sample separation was performed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-201 
PAGE). Protein transfer was carried out using the iBlot Gel Transfer Device (Invitrogen) following the manufacturer 202 
instructions. The membrane was blocked for 1 h in blocking buffer (TBS/Tween-20/5% milk) at 20
 o
C and then 203 
incubated overnight at 4 °C with 1:3000 dilution of Lck monoclonal antibody (#MA1-19197, Thermo Fisher Scientific, 204 
Rockford, IL, USA). The membrane was washed 3×5 min at 20 ºC in TBS/Tweeen-20 buffer before incubating with 205 
the horseradish peroxidase (HRP)-conjugated IgG secondary antibody (#ab99697, Abcam) for 1 h at 20 ºC. 206 
Afterwards, the membrane was washed 3×10 min with TBS/Tween-20 and visualized by using the ECL method. 207 
 208 
3. Results and discussion 209 
 210 
3.1. Qualitative analysis of the Human Jurkat T cell phosphoproteome  211 
In this study, we used human Jurkat T cells (JE6.1 and Jgamma1 clones) as a model to analyze the phosphorylation 212 
changes of human T cells upon costimulation with anti-CD3/anti-CD28 antibodies. The Jgamma1 clone is a PLC--213 
null T-cell which was originally prepared by mutagenesis and clonal selection from Jurkat WT cells [32]. Jgamma1 214 
shows no expression of PLC- which results in impaired Ca+ mobilization after TCR activation. Despite a small, 215 
transient rise in Ca
+2
 was still produced probably due to the action of the PLC-2, a minor PLC isoform in T-cells, no 216 
N-FAT activation or interleukin 2 production was observed in this clone. Although some differences between the two 217 
cell clones studied could be due to possible unknown mutagenesis-induced alterations in Jgamma1, these two clones 218 
constitute an accepted model for the study of the effect of the lack of PLC- expression in T-cells [33-35]. 219 
 220 
Experiments involved 5 biological replicates performed on different days. For each replicate, aliquots of 2.5×10
7
 cells 221 
were activated for 15, 30, 60, 120 and 1440 min with antibodies (Figure 1). Common time-courses used for T-cell 222 
activation in quantitative proteomics studies range from seconds to several minutes [8, 12, 15] and up to 60 min [10]. 223 
In order to get an insight on late phosphorylation events, and taking advantage of the capability of TMT labelling for 224 
monitoring of up to 6 samples in parallel, we extended the activation time range up to 1440 min. However, probably 225 
due to the lack of FBS in the culture media and the high density of cells required for the activation, 95% cells died 226 
after the longer incubation/activation time (as observed by trypan blue staining). In consequence, the corresponding 227 
analytical data was discarded and thus the 1440 min time point was not taken into consideration for the following 228 
discussion. For the analysis, eighty micrograms of protein from control and treated cells were digested and labeled 229 
with the corresponding TMT reagents. The pooled TMT-labelled samples were separated into 6 fractions by SCX 230 
chromatography and each fraction was subjected to phosphopeptide enrichment by sequential IMAC and TiO2 231 
chromatography [24]. The IMAC and TiO2 phosphopeptide fractions were analyzed separately by nanoLC-MS
n
. 232 
According to the database matching strategy described in Experimental and elsewhere [24, 25], hits detected from at 233 
least two search engines were considered as positive identifications. 234 
 235 
On average, we identified 2212 and 2078 non-redundant phosphopeptides per biological replicate in JE6.1 and 236 
Jgamma1, respectively (Table S0). In total, we identified 5585 non-redundant phosphopeptides matching 2008 237 
different phosphoproteins from both cell clones. Among them, the numbers of detected non-redundant 238 
phosphopeptides and phosphoproteins in JE6.1 are slightly higher than those in Jgamma1. Notably, 2732 239 
phosphopeptides (48.9%) and 1317 proteins (65.6%) are common to both cell clones (Fig. 2A and 2B, full sets of 240 
phosphopeptides and phosphoproteins are provided in Supplemental Tables S1 and S2). Although MS-based large 241 
scale phosphoproteomics studies are able to identify thousands of phosphorylated peptides, confident site 242 
localization remains challenging. The confident localization of phosphorylation events on a given peptide can be 243 
evaluated using several scoring algorithms including Ascore [25, 28], MD-score [36], LuciPHOr [37] or PhosphoRS 244 
[38]. In the set of the identified phosphopeptides, 3189 and 2955 phosphopeptides containing high confidence P-sites 245 
according to the Q-Ascore algorithm were detected in JE6.1 and Jgamma1, respectively. By comparing with the 246 
PhosphositePlus database [39], we identified 130 and 114 novel phosphopeptides containing only high confidence P-247 
sites in JE6.1 and Jgamma1, respectively (Supplemental Table S3). Eleven of these sites in each clone had been 248 
annotated previously in other species, and other 9 and 7 sites in JE6.1 and Jgamma1, respectively, were annotated 249 
as predicted in the database but there was not experimental evidence in humans. More importantly, about 60 new 250 
phosphopeptides containing high confidence P-sites, and with unequivocal protein assignation (pointing each to a 251 
single protein), were discovered from each cell clone (63 in JE6.1 and 57 in Jgamma1). These phosphopeptides 252 
represent new high confidence P-sites on their corresponding proteins (Supplemental Table S2). 253 
 254 
3.2. Effects of PLCγ1 in human T cell’s phosphorylation dynamics 255 
Upon TCR stimulation, PLCγ1 is activated by ITK and catalyzes the formation of IP3 and DAG from PIP2, initiating 256 
numerous cellular events including Ca
2+
- and DAG-induced responses, cytoskeletal rearrangements, and integrin 257 
activation pathways [5, 6]. An abnormal PLCγ1 activity results in changes of constitutive cell signaling pathways, and 258 
has been described as a potential risk of cancer. Vaqué et al. [40] reported that the acquisition of somatic mutations 259 
in PLCγ1 and other essential genes for normal T cell differentiation may affect the proliferation and survival 260 
mechanisms in cutaneous T cell lymphomas (CTCL). Data from another study [41] indicated the role of PLC γ1-261 
R707Q mutation in representing an alternative way of activation of kinase insert domain receptor (KDR)/PLCγ1 262 
signaling in angiosarcomas. In T cell signaling, PLCγ1 is central on the TCR-dependent proximal signaling complex 263 
through interacting with SLP-76, Vav1 and LAT [3, 5, 6]. To date, the effects of PLCγ1 on the T cell 264 
phosphoproteome is still poorly understood.  265 
 266 
The present work introduces for the first time the phosphoproteome of Jgamma1 and the effect of PLCγ1 on 267 
phosphorylation dynamics of human T cells. For this purpose we analyzed the phosphorylation state of JE6.1 (wild 268 
type) and Jgamma1 (PLCγ1 null) upon CD3/CD28 costimulation at different time points (15, 30, 60, and 120 min). 269 
Cell activation was verified by Western blot analysis of two proteins involved in TCR signaling: the ribosomal protein 270 
S6 and the extracellular signal-regulated kinase 1/2 (ERK 1/2) (data not shown). 271 
 272 
Overall, we identified 378 phosphopeptides (matched to 332 phosphoproteins) containing regulated P-sites in JE6.1, 273 
whereas only 71 phosphopeptides (matched to 71 phosphoproteins) containing regulated P-sites were detected in 274 
Jgamma1 (Supplemental Table S4 and S5). Several kinases were identified in the set of regulated proteins (18 and 3 275 
in JE6.1 and Jgamma1 clones, respectively, Supplemental Tables S6). Significant phosphorylation changes were 276 
observed in cyclin-dependent kinases 1, 11B, 12 and 13 in JE6.1 clone. The lower number of phosphoproteins and 277 
phosphopeptides containing regulated P-sites after TCR stimulation in the case of Jgamma1 probably reflects the 278 
vital role of PLCγ1 on TCR-driven signal transduction. Among the phosphopeptides containing regulated P-sites, 21 279 
phosphopeptides (matched to 27 phosphoproteins) were common to both cell clones (Fig. 2C). The amino acid 280 
distribution (S/T/Y) of regulated P-sites was similar to that observed from non-regulated P-sites in both cell clones. 281 
Detectability of phosphorylation changes depends both in the detectability of the phosphopeptide (determined by the 282 
size, physicochemical characteristics, concentration of the tryptic sequence bearing the modification and the 283 
existence of possible co-eluting interferences) and the production of quantitative data of enough precision to reveal 284 
small changes that can be physiologically relevant. The observation window provided by shotgun approaches is 285 
being widened by the advances in the mass resolution and scan speed of modern MS instruments as well as by the 286 
development of more precise quantitative strategies [42]. Still, due to the inherent characteristics of the data-287 
dependent shotgun approach, the number of sites reported here are doubtless only a fraction of the sites undergoing 288 
modification after TCR-activation. 289 
 290 
3.3. Motif analysis of regulated phosphopeptides 291 
Motif-X analysis of the high confidence phosphopeptide sets in our collections revealed the presence of several 292 
kinase substrate motifs including proline-directed, basophilic, and CK2 motifs in both cell types (Figure S2). The most 293 
frequent motif was the proline directed motif (xxxsPxx), specific for extracellular signal-regulated kinases 1 and 2 294 
(ERK1/2), glycogen synthase kinase 3 (GSK-3) and cyclin-dependent-like kinase 5 (CDK-5) [30, 43]. This motif was 295 
also the most abundant in the collections of regulated P-sites from both clones. The second most frequent motif in the 296 
full collection was a basophilic CaMK2 motif (RxxSxxx) which was also very frequent in the sets of regulated 297 
phosphopeptides. These proline-directed and basophilic motifs have been reported to be regulated in human Primary 298 
T cells after 5 min activation with anti-CD3 antibodies [44]. The most specific motif (extracted in the first iteration of 299 
the Motif-X analysis) appearing in the full phosphosite collection (RxxsPxxx) has been recently described as specific 300 
for SR protein kinases [45], a family of proteins involved in RNA splicing. Interestingly, this motif did not appear when 301 
only the set of regulated phosphopeptides were considered in the Motif-X analysis, suggesting that the corresponding 302 
kinases are not playing a major role during cell activation. Similar profiles of proline-directed (xxxSPxx), basophilic 303 
(RRxxSxxxx and RxxSxxx), and CK2 (xxxSDxE and xxxSxxE) motifs were observed in JE6.1 when considering only 304 
the set of high confidence up-regulated phosphopeptides. In the case of Jgamma1, the proline directed motif is also 305 
observed among the up-regulated phosphopeptides although the motif with a higher score is a RxxxxSxxxxx motif 306 
which is present in 28% of the Jgamma1 final unique target peptides accepted by Motif-X. This motif has been 307 
reported as a partial motif for Akt kinase (canonical substrate motif RxRxxS/T) [46], a protein involved in cell 308 
proliferation and survival through the PI3K/Akt signalling pathway and mTOR activation. The peptides bearing the 309 
RxxxxSxxxxx motifs pointed to 9 different proteins, including proteins related with T-Cell activation such as Lck (Ser-310 
94) and DOCK2 (Ser-1705). As the number of upregulated phosphopeptides available for Motifs-X analysis was 311 
relatively low, confirmation of the differential presence of this motif on Jgamma1 would require further studies 312 
 313 
3.4. Phosphoproteins containing regulated P-sites 314 
Proteins containing regulated P-sites in JE6.1 were mapped into 13 different functional KEGG pathways by using 315 
DAVID analysis (Fig.3, p value < 0.05) [31]. Involved pathways, as those of the spliceosome, mitogen-activated 316 
protein kinase (MAPK), TCR signaling, and actin and cytoskeleton regulation reflect the well-known activities 317 
occurring during T cell activation [5, 6]. In Jgamma1, regulated P-sites-containing proteins map only to the 318 
spliceosome pathway, the gap junction pathway and other two KEGG pathways not related with cell activation 319 
(pathogenic E.coli infection and systemic lupus erythematosus). The difference on the represented pathways 320 
between JE6.1 and Jgamma1 could be explained by the negative influence of PLCγ1 deficiency on phosphorylation 321 
of TCR-responsive proteins. In contrast, we observed in both cell clones several common downstream PLCγ1 322 
proteins containing up-regulated P-sites which are known to be related with TCR stimulation such as tubulins alpha-323 
1B chain (TUBA1B), beta-4A chain (TUBB4A) and beta chain (TUBB). Mayya et al. [10] found that TCR stimulation 324 
by OKT3 lead to phosphorylation changes of multiple isoforms of tubulin and described the role of this 325 
phosphorylation in microtubule polarization. The phosphorylation changes of these downstream PLCγ1 proteins may 326 
suggest the existence of PLCγ1 independent pathways in response to CD3/CD28 costimulation of T cells. 327 
 328 
Another protein related with microtubule polarization in our collection was stathmin. It has been described that 329 
phosphorylation of this protein on serine-25 and serine-38 abrogates its binding to microtubules contributing to their 330 
stabilization [10]. We found stathmin peptides phosphorylated on serine-16, serine-25 and serine-38. Serine-38 331 
showed a significant, small increase at 30 min in JE.1 but none of the monophosphorylated peptides containing 332 
serine-16 or serine-25 showed a significant change after activation. Interestingly, the doubly phosphorylated peptide 333 
at serine-16 and serine-25 showed a significant up-regulation at all activation times in JE.1, especially at 15 and 30 334 
min, suggesting a possible role of serine-16 in the activities assigned to serine-25. Contrarily to that observed in JE.1, 335 
this di-phosphorylated peptide was found down-regulated in Jgamma1 as well as the peptide phosphorylated at 336 
serine-25. None of the other two monophosphorylated peptides was detected in this clone. These results indicate the 337 
need of an unaltered pathway for stathmin phosphorylation at these sites.  338 
 339 
Spliceosomal proteins make up the largest group in both cell clones (Figure 3). Phosphorylation and 340 
dephosphorylation of these proteins have been found to modulate protein–protein and protein–RNA interactions [47]. 341 
Shi et al. [48] suggested that changes in proteins such as SF3b155 and U5-116K could modulate the rearrangement 342 
of the spliceosome structure at the initial step of splicing. On the other hand, phosphorylation of several other 343 
spliceosomal proteins such as Prp6, Prp31, and hPrp28 is essential for the formation of the spliceosomal B-complex 344 
[49, 50]. These phosphorylation/dephosphorylation events trigger the critical nuclear ribonucleoprotein (RNP) 345 
rearrangement, thereby allowing the spliceosome machinery to function [51]. Mayya [10] detected changes in 346 
phosphorylation of 5 SR family proteins and 7 spliceosomal proteins after treatment with OKT3. Our work presents 16 347 
and 9 proteins with phosphorylation changes in JE6.1 and Jgamma1, respectively, after T cell costimulation with anti-348 
CD3/anti-CD28 antibodies. These findings may support the proposition from Mayya that phosphorylation seems to 349 
play a role in splicing of mRNAs after TCR stimulation. 350 
 351 
We detected 33 phosphoproteins (from 27 protein nodes) and 26 phosphoproteins (from 22 protein nodes) from the 352 
KEGG-TCR signaling pathway in JE6.1 and Jgamma1, respectively; of them, 8 proteins showed significant 353 
phosphorylation changes upon CD3/CD28 costimulation in JE6.1, whereas only 1 protein (Lck) containing regulated 354 
P-sites was found out in Jgamma1 (Fig. 4). Notably, the only protein containing regulated P-sites (Lck) found in 355 
Jgamma1 is located upstream of PLCγ1 in the TCR signaling pathway, while no proteins with regulated P-sites were 356 
found downstream. Clearly, there is no significant difference in the number of phosphoproteins assigned to the 357 
KEGG-TCR signaling pathway between JE6.1 and Jgamma1. However, the number of proteins for which we 358 
detected regulated phosphopeptides in JE6.1 is remarkably higher than in Jgamma1. Thus, the absence of PLCγ1 359 
seems to affect more the protein phosphorylation dynamics than the phosphorylation state in Jurkat T cells stimulated 360 
with anti-CD3/anti-CD28 antibodies. 361 
 362 
3.5. Phosphorylation of Lck 363 
Lck - a typical member of the SRC family kinase is one of the first molecules to be activated following TCR 364 
stimulation. Upon antigen recognition by the TCR complex, Lck molecules are attracted towards the TCR and 365 
phosphorylate tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the 366 
cytoplasmic tails of the TCR-gamma chains and CD3 subunits, thereby initiating the TCR/CD3-dependent signaling 367 
pathways (reviewed in [5, 52]). Many P-sites from Lck have been identified, of which tyrosine-394 and tyrosine-505 is 368 
among the most important. The enzymatic activity of Lck is increased by the autophosphorylation on tyrosine-394 and 369 
decreased by the phosphorylation on tyrosine-505 by C-terminal Src kinase (CSK) [53, 54]. In this work, we detected 370 
14 P-sites on Lck from both cell clones; 13 of them are high confidence based on the Q-Ascore algorithm (Table 1).  371 
Prominently, besides the previously described P-sites, we detected four high confidence P-sites on Lck for which 372 
there was no experimental evidence for humans in PhosphositePlus database: serine-150, serine-377, serine-121, 373 
and serine-94. Phosphorylated serine-94, a site characterized in mouse in the database, was detected to be up-374 
regulated only in the case of the Jgamma1 clone while serine-121 was found significantly increased in both clones 375 
after stimulation. The serine-121 phosphorylation level was observed to gradually increase over time although 376 
changes were higher in the case of JE6.1 (Figure 5A). This suggests that this phosphorylation is not related with the 377 
role of this protein in the initial events of TCR-triggered signaling occurring through the protein complexes in the 378 
membrane. In addition, and despite Lck is a protein typically acting upstream of PLC, the increase in serine-121 379 
phosphorylation was very minor in the Jgamma1 clone, indicating that PLC or other downstream kinases could be 380 
involved in the process. Recently the translocation of Lck to the nucleus of primary and Jurkat T cell lines has been 381 
described, where it would act as a transcription factor [55, 56]. It has been shown that this translocation requires 382 
phosphorylation of tyrosine-394 which is in turn induced by TCR activation. Thus, the observed Lck phosphorylation 383 
at serine-121 could be related with this nuclear role and late events in response to TCR activation such as cell 384 
proliferation and for which functional PLC- is required.   385 
 386 
Due to the potential interest of this finding, we further validated the characterization of the site and the characteristics 387 
of the observed changes. As mentioned above, the localization of P-sites on peptides could be validated by several 388 
scoring algorithms. However, the localization of P-sites on a protein is not always obtained due to the issue of shared 389 
peptides between multiple proteins. For example, in our collection, about half of the identified phosphopeptides from 390 
each cell clone (53.8% in JE6.1 and 53.9% in Jgamma1) could be assigned to 2 or more proteins. In the case of Lck, 391 
serine-121 was unambiguously identified by the same phosphopeptide in both cell clones (there is only one potential 392 
phosphorylation site in the peptide). A BLAST search against the Uniprot database (http://www.uniprot.org/) showed 393 
that this phosphopeptide might belong to several isoforms of Lck in addition to a few proteins of low experimental 394 
evidence. Besides the main Lck isoform (P06239), the peptide also matched to isoforms 2 and 3 of the protein. In all 395 
cases the P-site was located at position 121 of the protein. This indicated that phosphorylation changes observed in 396 
this phosphopeptide probably reflect changes on the corresponding Lck sequence. These changes were due to a 397 
higher proportion of phosphorylated versus non phosphorylated protein as indicated by Western blot experiments that 398 
showed no significant changes on the levels of total Lck over time (Figure 5B). To our knowledge, this is the first 399 
evidence of phosphorylation at Serine-121 on Lck, a novel P-site regulated as a late response to TCR costimulation 400 
with anti-CD3/anti-CD28 antibodies.  401 
 402 
4. Conclusions 403 
We are reporting more than one hundred Jurkat phosphopeptides (130 and 114 peptides in the JE6.1 and Jgamma1 404 
clones, respectively), from a collection of more than 2000 proteins, which were not previously described in the 405 
PhosphositePlus database, probably the most comprehensive collection of phosphosites available.  406 
Quantitative analysis showed a remarkably lower number of phosphopeptides containing regulated P-sites in the 407 
Jgamma1 clone (71 phosphopeptides) compared to that in the JE6.1 clone (378 phosphopeptides), reflecting the vital 408 
role of PLCγ1 in T cell signaling. 409 
We discovered 4 high confidence novel P-sites on Lck in response to CD3/CD28 costimulation, of which serine-121 410 
showed significant changes in JE6.1 while only small changes in Jgamma1. These differences, together with the fact 411 
that Lck is a protein located upstream of PLCγ1 and that the observed phosphorylation takes place at long activation 412 
times, suggest that serine-121 phosphorylation could be involved in activities different to those occurring at the early 413 
stages of TCR-activation through the plasma  membrane complexes. Further studies would be required to ascertain 414 
whether this late phosphorylation event is related with the nuclear roles previously described for the protein. 415 
 416 
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FIGURES  571 
Figure 1. Jurkat T cells were activated with anti CD3/CD28 antibodies. Protein extracts were digested and labeled 572 
with the corresponding TMT reagents and the pooled material separated into 6 fractions by SCX chromatography. 573 
Each fraction was subjected to sequential IMAC and TiO2 chromatography and the resulting phosphopeptide 574 
fractions were analyzed separately by nanoLC-MS
n
. The full study comprised five biological replicates. 575 
 576 
Figure 2. Overview of the phosphopeptide and phosphoprotein sets identified in JE6.1 and Jgamma1 cell clones. A) 577 
Non-redundant phosphopeptides and B) phosphoproteins identified. C) Non redundant phosphopeptides containing 578 
P-sites which were found regulated upon TCR activation. 579 
 580 
Figure 3. KEGG pathway mapping of proteins containing regulated P-sites. All pathways shown are overrepresented 581 
in JE6.1 (p<0.05) while only the spliceosome, pathogenic E.coli infection, gap junction and systemic lupus 582 
erythematosus pathways passed the filter for Jgamma1. 583 
 584 
Figure 4. KEGG-TCR signaling pathway of phosphoproteins detected in the JE6.1 and Jgamma1 cell clones. The 585 
red-filled shapes represent proteins containing regulated P-sites. 586 
 587 
Figure 5. Phosphorylation changes at Serine-121 of Lck measured by mass spectrometry across the time course (A) 588 
and total Lck protein expression by Western blot analysis (B). Stars indicate adjusted P-value <0.05. 589 
 590 
 591 
 592 
 593 
Table 1. P-sites of LCK detected in the JE6.1 and Jgamma1 cell clones. New P-sites (not described in 
PhosphoSiteDB) are indicated in the PhosphoSiteDB column. 
No P-sites 
Q-Ascore * 
PhosphoSitePlus Regulation** 
JE6 JGM 
1 Tyrosine-505 97.7 123.5 Yes NC 
2 Threonine-210 40 ___ Yes NQ 
3 Serine-213 33.8 ___ Yes NQ 
4 Serine-150 81.2 95.5 No NC 
5 Threonine-198 1000 ___ Yes NQ 
6 Serine-377 42.9 14.2 No NQ 
7 Serine-121 1000 1000 No Up-regulated, 
lightly on gamma1 
strongly on JE.1 
8 Threonine-159 6.1 ___ Yes NQ 
9 Serine-162 17.7 ___ Yes NQ 
10 Serine-94 1000 1000 No*** Up-regulated in 
Jgamma1 
11 Tyrosine-394 ___ 28 Yes NC 
12 Threonine-395 ___ 1000 Yes NC 
13 Serine-194 ___ 1000 Yes NC 
14 Tyrosine-470 ___ 1000 Yes Up-regulated in 
Jgamma1 
* 1000, unambiguous P-site, only 1 phosphorylation target residue; 
___
, non-detected. 
** NC, no significant change; NQ, non-quantified, 
*** described in rat  
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